August 25, 2022 Comments Off on New patent for Exeltis Usa drug SLYND Posted in: Patent Added Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug. SLYND drug…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch -…
August 25, 2022 Comments Off on New patent for Catalyst Pharms drug FIRDAPSE Posted in: Patent Added Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on Dr…
